HCA Healthcare (NYSE:HCA) had its price target boosted by Morgan Stanley from $115.00 to $124.00 in a research report sent to investors on Wednesday. They currently have an underweight rating on the stock.
HCA has been the topic of a number of other research reports. SunTrust Banks upped their price target on HCA Healthcare to $150.00 and gave the stock a positive rating in a report on Tuesday. Zacks Investment Research upgraded HCA Healthcare from a hold rating to a buy rating and set a $119.00 price target on the stock in a report on Monday, July 16th. Cantor Fitzgerald restated a buy rating and issued a $115.00 price target on shares of HCA Healthcare in a report on Friday, July 20th. JPMorgan Chase & Co. upped their price target on HCA Healthcare to $151.00 and gave the stock an overweight rating in a report on Monday, July 30th. Finally, ValuEngine cut HCA Healthcare from a buy rating to a hold rating in a report on Thursday, June 28th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $123.05.
NYSE HCA opened at $133.79 on Wednesday. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36. HCA Healthcare has a 12-month low of $71.18 and a 12-month high of $138.18. The company has a market cap of $46.41 billion, a price-to-earnings ratio of 16.87, a price-to-earnings-growth ratio of 1.21 and a beta of 0.54.
HCA Healthcare (NYSE:HCA) last released its earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company had revenue of $11.53 billion for the quarter, compared to analysts’ expectations of $11.32 billion. During the same quarter in the previous year, the firm posted $1.73 EPS. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. equities research analysts forecast that HCA Healthcare will post 9.23 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Investors of record on Tuesday, September 4th will be paid a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Friday, August 31st. HCA Healthcare’s payout ratio is currently 21.24%.
In related news, SVP Jane D. Englebright sold 6,543 shares of the company’s stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total value of $849,673.98. Following the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Victor L. Campbell sold 22,782 shares of the company’s stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $127.12, for a total value of $2,896,047.84. Following the completion of the sale, the senior vice president now directly owns 202,650 shares in the company, valued at approximately $25,760,868. The disclosure for this sale can be found here. In the last ninety days, insiders sold 209,507 shares of company stock worth $25,305,075. 2.80% of the stock is owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of HCA. Motley Fool Asset Management LLC lifted its stake in shares of HCA Healthcare by 12.5% during the 2nd quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock worth $382,000 after purchasing an additional 412 shares during the period. Banque Pictet & Cie SA lifted its stake in shares of HCA Healthcare by 0.5% during the 2nd quarter. Banque Pictet & Cie SA now owns 91,929 shares of the company’s stock worth $9,432,000 after purchasing an additional 480 shares during the period. Gideon Capital Advisors Inc. lifted its stake in shares of HCA Healthcare by 14.7% during the 2nd quarter. Gideon Capital Advisors Inc. now owns 4,441 shares of the company’s stock worth $456,000 after purchasing an additional 569 shares during the period. Intrust Bank NA lifted its stake in shares of HCA Healthcare by 0.8% during the 2nd quarter. Intrust Bank NA now owns 74,417 shares of the company’s stock worth $7,635,000 after purchasing an additional 620 shares during the period. Finally, Huntington National Bank lifted its stake in shares of HCA Healthcare by 11.2% during the 2nd quarter. Huntington National Bank now owns 6,442 shares of the company’s stock worth $661,000 after purchasing an additional 648 shares during the period. 70.40% of the stock is currently owned by hedge funds and other institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: Discover Your Risk Tolerance
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.